Scott Letter: Closed-End Fund Report Interview with Tekla Capital Management’s Dr. Daniel Omstead. They Have Three Healthcare Funds (HQH, HQL, THQ) – [Free Sign-Up Required]
October 6, 2014, Richmond, VA.— Closed-End Fund Advisors is pleased to announce an in-depth interview in The Scott Letter: Closed-End Fund Report with Dr. Daniel R. Omstead. He is President and CEO of Tekla Capital Management, LLC
(“Tekla”). He is also President of H&Q Lifesciences Investors and H&Q Healthcare Investors.
We found the interview to be a timely update on how investors could gain access to Biotech and Healthcare stocks (public and private) as well as their new fund (THQ) focused on a more income based healthcare strategy. We also discuss how the funds are being positioned in the current economic and interest rate environment. If you are not already a subscriber to The Scott Letter, a subscription is free on our website www.CEFadvisors.com.
Once you sign-up, you will receive the interview as well as gain access to our firm’s periodic email updates on our services, CEF markets and various articles, videos, webinars and live CEF conferences or meetings we host or are otherwise involved with in some way.
Free Scott Letter Registration: www.cefadvisors.com/scottletter.html.